Aarti Surfactants Ltd. AI Stock Analysis
Want to see IN:AARTISURF full AI Analyst Report?
Aarti Surfactants Ltd. (AARTISURF) AI Stock Analysis
Aarti Surfactants Ltd.
(NSE:AARTISURF)
Moderate financial performance driven by revenue expansion and balance sheet improvement is the primary positive factor, while mixed technical signals with short-term weakness provide a slight offset and valuation remains fair.
Aarti Surfactants Ltd. (AARTISURF) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 4.49B
- Dividend Yield
- 0.19%
- Average Volume (3M)
- 1,334
- Price to Earnings (P/E)
- 24.4
- Beta (1Y)
- 1.51
- Revenue Growth
- 25.22%
- EPS Growth
- 20.38%
- Country
- India
- Employees
- 393
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Aarti Surfactants Ltd. Business Overview & Revenue Model
Company Description
Aarti Surfactants Limited, in conjunction with its subsidiary Aarti HPC Limited, specializes in the production and global distribution of a diverse range of surfactants, including ionic, non-ionic, and specialty types. These crucial chemical compound...
Aarti Surfactants Ltd. Financial Statement Overview
Summary
Revenue growth from 4.6B to projected 8.6B supported by strengthening balance sheet with debt-to-equity improving to 0.43, though volatile profit margins and cash flows limit the score.
Income Statement
55NeutralBalance Sheet
75PositiveCash Flow
65Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.16B | 8.59B | 6.59B | 5.86B | 5.97B | 5.70B |
| Gross Profit | 1.18B | 947.78M | 1.25B | 990.42M | 1.23B | 794.12M |
| EBITDA | 560.00M | 468.81M | 419.18M | 621.92M | 477.40M | 324.31M |
| Net Income | 183.99M | 123.42M | 145.45M | 213.27M | 127.05M | 54.95M |
Balance Sheet | ||||||
| Total Assets | 0 | 5.17B | 4.77B | 4.22B | 4.02B | 4.02B |
| Cash, Cash Equivalents and Short-Term Investments | 134.31M | 134.31M | 12.07M | 63.15M | 76.89M | 14.29M |
| Total Debt | 0 | 1.04B | 1.10B | 992.09M | 1.49B | 1.62B |
| Total Liabilities | -2.45B | 2.72B | 2.45B | 2.04B | 2.36B | 2.67B |
| Stockholders Equity | 2.45B | 2.45B | 2.33B | 2.18B | 1.68B | 1.36B |
Cash Flow | ||||||
| Free Cash Flow | -8.16M | 201.22M | -90.98M | 356.08M | 139.31M | 7.76M |
| Operating Cash Flow | 216.41M | 652.27M | 111.38M | 519.61M | 247.84M | 233.18M |
| Investing Cash Flow | -239.22M | -450.85M | -161.63M | -162.19M | 85.61M | -225.41M |
| Financing Cash Flow | 16.49M | -79.18M | -3.67M | -371.15M | -270.86M | -60.80M |
Aarti Surfactants Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:AARTISURF, the sentiment is Positive. The current price of 528.30 is above the 20-day moving average (MA) of 475.85, above the 50-day MA of 496.61, and above the 200-day MA of 434.60, indicating a bullish trend. The MACD of 2.53 indicates Negative momentum. The RSI at 64.12 is Neutral, neither overbought nor oversold. The STOCH value of 95.56 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:AARTISURF.
Aarti Surfactants Ltd. Peers Comparison
Overall Rating
IN:FINEORG74.75Outperform
IN:GALAXYSURF67.9Neutral
IN:ROSSARI65Neutral
IN:AVTNPL63Neutral- IN:AARTISURF61Neutral
IN:CAMLINFINE42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| IN:FINEORG | 75Outperform | INR 162.72B | 33.63 | ― | 0.21% | 12.93% | 18.83% |
| IN:GALAXYSURF | 68Neutral | INR 78.67B | 19.28 | ― | 1.80% | 30.18% | 42.10% |
| IN:ROSSARI | 65Neutral | INR 24.27B | 15.81 | ― | 0.11% | 19.76% | 11.74% |
| IN:AVTNPL | 63Neutral | INR 14.68B | 17.57 | ― | 0.83% | 41.25% | 65.19% |
| IN:AARTISURF | 61Neutral | INR 4.48B | 24.39 | ― | 0.19% | 25.22% | 20.38% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| IN:CAMLINFINE | 42Neutral | INR 14.77B | -183.02 | ― | ― | 7.92% | 73.43% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:AARTISURF | Aarti Surfactants Ltd. | 528.30 | 79.47 | 17.71% | |
| IN:AVTNPL | AVT Natural Products Limited | 96.40 | 24.64 | 34.33% | |
| IN:CAMLINFINE | Camlin Fine Sciences Limited | 76.90 | -93.05 | -54.75% | |
| IN:FINEORG | Fine Organic Industries Ltd. | 5307.30 | 738.57 | 16.17% | |
| IN:GALAXYSURF | Galaxy Surfactants Ltd. | 2218.90 | 74.56 | 3.48% | |
| IN:ROSSARI | Rossari Biotech Ltd | 438.10 | -191.74 | -30.44% |
Aarti Surfactants Ltd. Corporate Events
Aarti Surfactants Widens Business Scope With Revised Memorandum of Association
Aarti Surfactants Ltd. has secured shareholder approval at its eighth annual general meeting to alter the main object clause of its Memorandum of Association, effectively expanding and clarifying the scope of its permitted business activities in chem...
Aarti Surfactants Holds Eighth AGM with Clean Audit for FY 2025-26
Aarti Surfactants Ltd. conducted its eighth Annual General Meeting on September 29, 2026 via video conferencing and other audio-visual means, complying with guidance from the Ministry of Corporate Affairs and SEBI. Fifty-eight shareholders participat...
Aarti Surfactants Discloses AGM Investor Presentation to Exchanges
Aarti Surfactants Limited informed stock exchanges that it delivered an investor presentation to shareholders at its eighth Annual General Meeting held on September 29, 2026. The disclosure, made under SEBI’s listing regulations, underscores the comp...
Aarti Surfactants Discloses Resignation of Independent Director Nisha B. Shah
Aarti Surfactants Ltd. has announced the resignation of Mrs. Nisha B. Shah from her role as Non-Executive Independent Director, effective from the close of business on September 11, 2026. The company disclosed that Shah has provided reasons in her re...
Aarti Surfactants Sets Virtual AGM as It Releases FY 2025-26 Annual Report
Aarti Surfactants Ltd., a listed player in the surfactants and specialty chemicals space, serves home and personal care as well as industrial markets with its portfolio of surface-active agents and related products. Its dual listing on BSE and NSE gi...
Aarti Surfactants Secures Rating Upgrade to Crisil A-/Stable on Rs 200 Crore Bank Facilities
Aarti Surfactants Ltd., a listed surfactants manufacturer serving home, personal care and industrial markets, disclosed a change in its credit rating agency from CARE Ratings to Crisil Ratings for its bank loan facilities. The company’s access to ins...
Aarti Surfactants sets up wholly owned U.S. subsidiary to expand global reach
Aarti Surfactants Ltd. has incorporated a wholly owned overseas subsidiary, Precision Ingredients USA Inc., in the State of Wyoming, United States, to handle marketing, import, export, and trading of surfactants, specialty chemicals, and allied produ...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 05, 2026